According to news from Zhaoyan New Pharmaceutical, recently, Zhaoyan Pharmaceutical joined hands with Zhao Derivatives and Shenglu Intelligence to sign a strategic cooperation agreement with Kyushu Express. The parties will cooperate on drug research and development, drug sales, early project investment, AI medical care and biomedical industry ecological parks to provide collaborative support for pharmaceutical companies from R&D to commercialization.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.